ClinicalTrials.gg
RecruitingNCT07581717PAVMSUpdated Jun 26, 2026

Computer-Assisted Comparison of Hip Socket Volume and Surface Shape After Pediatric Acetabular Osteotomies

An observational study in Developmental Dysplasia of the Hip (DDH), Developmental Dysplasia of the Hip and Acetabular Dysplasia, sponsored by Istanbul University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by Istanbul University · Observational

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
2 Years to 18 Years
Sex
All
01

Study summary

The goal of this observational study is to learn how four acetabular osteotomy techniques change the shape of the hip socket in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia.

The main questions it aims to answer are:

How do virtual Salter, Dega, San Diego, and Pemberton osteotomies differ in acetabular volume and surface shape on participant-specific three-dimensional models? How closely does the virtual result of the osteotomy actually performed match the early postoperative magnetic resonance imaging (MRI)?

Participants will have a three-dimensional pelvis-acetabulum model created from preoperative MRI. Researchers will perform virtual Salter, Dega, San Diego, and Pemberton osteotomies on that model and measure the resulting acetabular morphology. The virtual result of the osteotomy actually performed will then be compared with the participant's early postoperative MRI.

Read the detailed description

This is a single-center, prospective, observational methodological validation study in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia who are undergoing Salter, Dega, San Diego, or Pemberton acetabular osteotomy.

The study has two linked analytical components. First, participant-specific three-dimensional pelvis-acetabulum models will be generated from preoperative MRI obtained within 6 weeks before surgery. Standardized virtual Salter, Dega, San Diego, and Pemberton osteotomies will then be applied on each participant's preoperative model to compare the expected effect of each technique on acetabular volume, surface area, coverage distribution, and other predefined three-dimensional morphometric parameters.

Second, early postoperative MRI obtained 3 to 8 weeks after surgery will be used to derive actual postoperative three-dimensional morphology. The virtual output corresponding to the osteotomy actually performed clinically will then be compared with the postoperative MRI-derived morphology to quantify prediction accuracy using absolute difference, bias, and Bland-Altman limits of agreement.

Additional analyses will compare validation performance by osteotomy type, assess interobserver and intraobserver reliability, measure workflow feasibility, and explore associations between preoperative morphometric markers and prediction error.

02

Conditions studied

  • Developmental Dysplasia of the Hip (DDH)
  • Developmental Dysplasia of the Hip
  • Acetabular Dysplasia

Keywords

  • Salter osteotomy
  • Dega osteotomy
  • San Diego osteotomy
  • Pemberton osteotomy
  • Developmental dysplasia of the hip
  • Acetabular dysplasia
  • Magnetic resonance imaging
  • Three dimensional modeling
  • Acetabular morphometry
  • Methodological validation
03

In context

Developmental Dysplasia of the Hip

60 studies on the registry are indexed under Developmental Dysplasia of the Hip; 18 are open to participants now.

This study's planned enrollment of 12 is below the median of 72 across 21 observational studies indexed under Developmental Dysplasia of the Hip.

Browse Developmental Dysplasia of the Hip studies →

Lead sponsor

Istanbul University is the lead sponsor of 511 studies on the registry; 78 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia who are scheduled for primary Salter, Dega, San Diego, or Pemberton acetabular osteotomy at Istanbul University, Istanbul Faculty of Medicine

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 2 to 18 years
  2. Developmental dysplasia of the hip or residual acetabular dysplasia
  3. Primary Salter, Dega, San Diego, or Pemberton acetabular osteotomy planned at Istanbul University, Istanbul Faculty of Medicine
  4. Preoperative hip MRI available within 6 weeks before surgery
  5. Early postoperative hip MRI available 3 to 8 weeks after surgery
  6. MRI quality adequate for three-dimensional morphometric analysis
  7. Unilateral or bilateral cases eligible

Exclusion criteria

Exclusion Criteria:

  1. Hip pathology not related to developmental dysplasia of the hip, including Perthes disease, slipped capital femoral epiphysis, neuromuscular dysplasia, or infection/trauma sequelae
  2. Previous surgery on the same hip that significantly alters anatomy, including prior pelvic or femoral osteotomy or open reduction, or current metal implant/fusion
  3. MRI or safety issue, including MR-incompatible implant/device, severe claustrophobia, or a medical barrier to sedation/anesthesia
  4. MRI not compatible with protocol or inadequate for analysis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Patient registry
No

Groups and cohorts

  • Salter Osteotomy Cohort

    Participants with DDH or residual acetabular dysplasia undergoing primary Salter acetabular osteotomy as part of routine clinical care, with preoperative MRI-based 3D modeling and early postoperative MRI comparison.

    Procedure: Salter osteotomy

  • Dega Osteotomy Cohort

    Participants with DDH or residual acetabular dysplasia undergoing primary Dega acetabular osteotomy as part of routine clinical care, with preoperative MRI-based 3D modeling and early postoperative MRI comparison.

    Procedure: Dega osteotomy

  • San Diego Osteotomy Cohort

    Participants with DDH or residual acetabular dysplasia undergoing primary San Diego acetabular osteotomy as part of routine clinical care, with preoperative MRI-based 3D modeling and early postoperative MRI comparison.

    Procedure: San Diego osteotomy

  • Pemberton Osteotomy Cohort

    Participants with DDH or residual acetabular dysplasia undergoing primary Pemberton acetabular osteotomy as part of routine clinical care, with preoperative MRI-based 3D modeling and early postoperative MRI comparison.

    Procedure: Pemberton osteotomy

Interventions

  • ProcedureSalter osteotomy

    Redirectional innominate osteotomy performed to improve acetabular orientation and femoral head coverage in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia. The acetabulum is reoriented as a single fragment to increase primarily anterolateral coverage. The procedure is performed as routine clinical care, with technique selection based on the treating surgeon's indication and preoperative deformity pattern.

    Also known as: Salter innominate osteotomy

  • ProcedureDega osteotomy

    Incomplete transiliac acetabuloplasty performed to reshape the acetabular roof and improve femoral head coverage in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia. The osteotomy preserves a hinge at the triradiate cartilage, allowing tailored correction of acetabular deficiency according to the morphology of the dysplastic socket. The procedure is performed as routine clinical care, with technique selection based on the treating surgeon's indication and preoperative deformity pattern.

    Also known as: Dega acetabuloplasty

  • ProcedureSan Diego osteotomy

    Incomplete transiliac acetabuloplasty performed to improve acetabular coverage in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia. The procedure preserves a triradiate cartilage hinge and allows directional correction according to the location of acetabular deficiency, including posterolateral or lateral deficiency when appropriate. The procedure is performed as routine clinical care, with technique selection based on the treating surgeon's indication and preoperative deformity pattern.

    Also known as: San Diego acetabuloplasty

  • ProcedurePemberton osteotomy

    Pericapsular acetabuloplasty performed to reshape and redirect the acetabulum in children and adolescents with developmental dysplasia of the hip or residual acetabular dysplasia. The osteotomy uses the triradiate cartilage as a hinge and increases femoral head coverage by altering acetabular shape and orientation. The procedure is performed as routine clinical care, with technique selection based on the treating surgeon's indication and preoperative deformity pattern.

    Also known as: Pemberton pericapsular osteotomy

06

What researchers measure

Primary outcomes

  1. Osteotomy-type differences in simulated acetabular morphometry

    Comparison across virtual Salter, Dega, San Diego, and Pemberton osteotomies of predefined morphometric outputs on participant-specific preoperative 3-dimensional models, including acetabular volume (mm3), surface area (mm2), and angular parameters such as version and inclination (degrees).

    Time frame: Baseline (preoperative MRI-based virtual simulation, within 6 weeks before surgery)

  2. Virtual-to-actual agreement of postoperative acetabular morphometry for the clinically performed osteotomy

    Agreement between the matched virtual osteotomy and the actual postoperative morphology, assessed using predefined morphometric outputs including acetabular volume (mm3), surface area (mm2), and angular parameters such as version and inclination (degrees); summarized using absolute difference, bias, and Bland-Altman limits of agreement.

    Time frame: Baseline and early postoperative MRI (3 to 8 weeks after surgery)

Secondary outcomes

  1. Osteotomy-type differences in virtual-to-actual prediction error

    Comparison of validation error among clinically performed Salter, Dega, San Diego, and Pemberton osteotomies.

    Time frame: Baseline and early postoperative MRI (3 to 8 weeks after surgery)

  2. Interobserver reliability of MRI-based segmentation and morphometric measurements

    Interobserver agreement for segmentation and morphometric measurements, reported using intraclass correlation coefficients.

    Time frame: Baseline and early postoperative MRI (3 to 8 weeks after surgery)

  3. Intraobserver reliability of MRI-based segmentation and morphometric measurements

    Intraobserver agreement for repeat measurements, reported using intraclass correlation coefficients.

    Time frame: Baseline and early postoperative MRI (3 to 8 weeks after surgery)

  4. Workflow processing time

    Time required for segmentation, virtual osteotomy simulation, and morphometric analysis.

    Time frame: From baseline MRI acquisition to completion of early postoperative MRI analysis, up to 14 weeks

  5. Workflow completion rate

    Proportion of enrolled participants with a complete protocol-compatible analyzable dataset.

    Time frame: From baseline MRI acquisition to completion of early postoperative MRI analysis, up to 14 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • du Cluzel de Remaurin X, Khouri N, Georges S, Gajny L, Vergari C, Badina A. Methods for three-dimensional characterization of the acetabulum prior to pelvic reorientation osteotomy: a scoping review. EFORT Open Rev. 2024 Aug 1;9(8):762-772. doi: 10.1530/EOR-22-0126. PubMed 39087510 ↗
  • Badrinath R, Jeffords ME, Bomar JD, Ahmed SI, Pennock AT, Upasani VV. 3D Characterization of Acetabular Deficiency in Children with Developmental Dysplasia of the Hip. Indian J Orthop. 2021 Jul 23;55(6):1576-1582. doi: 10.1007/s43465-021-00458-7. eCollection 2020 Dec. PubMed 34987728 ↗
  • van Bosse H, Wedge JH, Babyn P. How are dysplastic hips different? A three-dimensional CT study. Clin Orthop Relat Res. 2015 May;473(5):1712-23. doi: 10.1007/s11999-014-4103-y. Epub 2014 Dec 19. PubMed 25524428 ↗
  • Caffrey JP, Jeffords ME, Farnsworth CL, Bomar JD, Upasani VV. Comparison of 3 Pediatric Pelvic Osteotomies for Acetabular Dysplasia Using Patient-specific 3D-printed Models. J Pediatr Orthop. 2019 Mar;39(3):e159-e164. doi: 10.1097/BPO.0000000000001271. PubMed 30300278 ↗
  • Zeng G, Schmaranzer F, Degonda C, Gerber N, Gerber K, Tannast M, Burger J, Siebenrock KA, Zheng G, Lerch TD. MRI-based 3D models of the hip joint enables radiation-free computer-assisted planning of periacetabular osteotomy for treatment of hip dysplasia using deep learning for automatic segmentation. Eur J Radiol Open. 2020 Dec 18;8:100303. doi: 10.1016/j.ejro.2020.100303. eCollection 2021. PubMed 33364259 ↗
  • Nakamura T, Wada A, Natori T, Kawaguchi K, Takamura K, Yanagida H, Yamaguchi T. A Novel Method for Assessing the 3-dimensional Morphology of Cartilaginous Acetabulum Via Childhood Magnetic Resonance Imaging. J Pediatr Orthop. 2023 Nov-Dec 01;43(10):640-648. doi: 10.1097/BPO.0000000000002510. Epub 2023 Sep 8. PubMed 37681305 ↗
  • Bellova P, Blum S, Hartmann A, Thielemann F, Gunther KP, Goronzy J. MRI-based assessment of acetabular version and coverage after previous Pemberton osteotomy in skeletally mature patients. J Child Orthop. 2021 Jun 1;15(3):223-231. doi: 10.1302/1863-2548.15.210010. PubMed 34211598 ↗

Individual participant data

Plan to share: Undecided — De-identified individual participant data are not planned to be shared with other researchers. Any future sharing would require additional review of participant confidentiality protections, institutional policy, and ethics approval. Aggregate study results may be reported in scientific publications and presentations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Sep 2026, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2026
First posted
May 12, 2026
StartActual
May 10, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 15, 2026
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07581717
Responsible party
Yavuz Saglam (Associate Professor of Orthopedics and Traumatology, Istanbul University) — Principal investigator
First posted
May 12, 2026
Start date
May 10, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Jun 26, 2026

Study contacts

Yavuz Sağlam, M.D.
Contact
yavuzsaglam84@istanbul.edu.tr
+90 536 320 5005
İsmail T. Atasoy, M.D.
Contact
tarik.atasoy@istanbul.edu.tr
+90 534 632 0870
Yavuz Sağlam, M.D.
principal investigator · Istanbul University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion